
CB Scientific, Inc.
OTC:CBSC
0.1347 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 0.126 | 0.136 | 0.427 | 0.019 | 0.015 | 0.008 | 0.005 | 0.012 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.126 | 0.136 | 0.427 | 0.019 | 0.015 | 0.008 | 0.005 | 0.012 |
Net Receivables
| 0.005 | 0.004 | 0.092 | 0.013 | 0.013 | 0.011 | 0.011 | 0.007 |
Inventory
| 0.028 | 0.023 | 0.009 | 0.154 | 0.081 | 0.013 | 0.015 | 0.023 |
Other Current Assets
| 0.017 | 0.016 | 0.001 | 0.125 | 0 | 0 | 0 | 0 |
Total Current Assets
| 0.175 | 0.18 | 0.529 | 0.311 | 0.109 | 0.032 | 0.03 | 0.042 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0.004 | 0.005 | 0.001 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.125 | 0.125 | 0 | 0 | 0 | 0 | 0.025 | 0.025 |
Total Non-Current Assets
| 0.125 | 0.125 | 0.125 | 0.001 | 0 | 0.004 | 0.03 | 0.026 |
Total Assets
| 0.3 | 0.305 | 0.654 | 0.312 | 0.109 | 0.036 | 0.061 | 0.068 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 0.033 | 0.024 | 0.01 | 0.009 | 0.014 | 0.1 | 0.149 | 0.148 |
Short Term Debt
| 0.021 | 0.1 | 0.044 | 0.384 | 0 | 0.357 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0.165 | 0.399 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 0.607 | 0.159 | 0.111 | 0.104 | 0.262 | 0.611 | 1.125 | 0.437 |
Total Current Liabilities
| 0.826 | 0.682 | 0.165 | 0.497 | 0.276 | 1.068 | 1.274 | 0.586 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 0 | 0 | 0 | 0.005 | 1.8 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0.117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0.117 | 0 | 0 | 0.005 | 1.8 | 0 | 0 | 0 |
Total Liabilities
| 0.943 | 0.682 | 0.165 | 0.502 | 2.075 | 1.068 | 1.274 | 0.586 |
Equity: | ||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Common Stock
| 0.154 | 0.13 | 0.112 | 0.082 | 0.059 | 0.059 | 0.059 | 0.057 |
Retained Earnings
| -16.33 | -14.7 | -12.637 | -6.295 | -1.967 | -1.536 | -1.718 | -0.587 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | -0.059 | -0.059 | -0.059 | -0.057 |
Other Total Stockholders Equity
| 15.533 | 14.193 | 13.014 | 6.023 | -0.01 | 0.494 | 0.553 | 0.059 |
Total Shareholders Equity
| -0.643 | -0.377 | 0.489 | -0.19 | -1.967 | -1.032 | -1.214 | -0.518 |
Total Equity
| -0.643 | -0.377 | 0.489 | -0.19 | -1.967 | -1.032 | -1.214 | -0.518 |
Total Liabilities & Shareholders Equity
| 0.3 | 0.305 | 0.654 | 0.312 | 0.109 | 0.036 | 0.061 | 0.068 |